698 / 1835
90
Y Ibritumomab Tiuxetan
treatment is completed in 7 days
Dosimetric dose:
Rituximab 250 mg/m
2
;
111
In Ibritumomab Tiuxetan 5mCi
111
In, 1.6 mg Ibritumomab Tiuxetan
Therapeutic dose: Rituximab 250 mg/m
2
;
90
Y Ibritumomab Tiuxetan 0.4mCi
90
Y for patients with platelet count >150,000
cells/mm
3
or 0.4 mCi/kg for a platelet count 100,000–149,000 cells/mm
3
0
+1
+2
+3
+4
+5
+6
Rituximab
5 scans
Days
+7
Followed by
111
In Ibritumomab Tiuxetan
Rituximab
Followed by
90
Y Ibritumomab Tiuxetan
DOSIMETRIC DOSE
THERAPEUTIC DOSE
Wiseman GA,
et al
.
Eur J Nucl Med
2000; 27: 766–77